FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 67 filers reported holding FORTRESS BIOTECH INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $88,000 | -14.6% | 35,177 | -45.1% | 0.00% | – |
| Q3 2018 | $103,000 | -39.1% | 64,102 | +13.0% | 0.00% | – |
| Q2 2018 | $169,000 | -37.6% | 56,727 | -4.7% | 0.00% | – |
| Q1 2018 | $271,000 | +17.3% | 59,510 | +2.6% | 0.00% | – |
| Q4 2017 | $231,000 | -10.8% | 57,979 | -1.1% | 0.00% | – |
| Q3 2017 | $259,000 | -7.8% | 58,630 | -1.0% | 0.00% | – |
| Q2 2017 | $281,000 | +32.5% | 59,224 | +3.3% | 0.00% | – |
| Q1 2017 | $212,000 | +35.9% | 57,311 | -0.8% | 0.00% | – |
| Q4 2016 | $156,000 | -7.1% | 57,795 | +1.9% | 0.00% | – |
| Q3 2016 | $168,000 | +9.1% | 56,695 | -0.9% | 0.00% | – |
| Q2 2016 | $154,000 | -12.5% | 57,196 | +0.6% | 0.00% | – |
| Q1 2016 | $176,000 | +9.3% | 56,852 | -1.6% | 0.00% | – |
| Q4 2015 | $161,000 | +5.2% | 57,784 | -1.9% | 0.00% | – |
| Q3 2015 | $153,000 | -22.7% | 58,922 | 0.0% | 0.00% | – |
| Q2 2015 | $198,000 | – | 58,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,573,600 | $3,750,352 | 1.12% |
| PERKINS CAPITAL MANAGEMENT INC | 1,419,013 | $1,164 | 1.10% |
| Nantahala Capital Management | 6,917,876 | $5,672,658 | 0.44% |
| SHIKIAR ASSET MANAGEMENT INC | 1,169,000 | $959 | 0.34% |
| Leucadia National | 2,850,000 | $2,337,000 | 0.02% |
| THOMPSON DAVIS & CO., INC. | 12,996 | $10,657 | 0.01% |
| Black Maple Capital Management LP | 15,000 | $12,300 | 0.01% |
| 1900 WEALTH MANAGEMENT LLC | 130,000 | $85,150 | 0.01% |
| Spotlight Asset Group, Inc. | 10,700 | $7 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,022,233 | $837 | 0.00% |